HHS Reinstates Employees Amid Restructuring Efforts
In a significant development, the Department of Health and Human Services (HHS) has formally revoked layoff notices for numerous employees, restoring positions at both the U.S. Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA). This decision, communicated on Tuesday, marks an important shift in staffing strategy within essential health programs.
Details of Reinstatement
Letters sent to affected employees clarified that previous layoff notifications were rescinded, indicating a more permanent restoration of positions rather than temporary extensions. Affected staff included personnel from the World Trade Center Health Program, which provides critical healthcare services to 9/11 first responders and survivors.
Background on Layoffs and Reinstatements
Last week, the HHS proposed cutting 15 positions at the 9/11 program as part of broader layoffs impacting the CDC’s National Institute of Occupational Safety and Health (NIOSH). This prompted severe backlash from lawmakers in New York, who voiced concerns about the implications for the program’s operations.
In response to growing concerns, HHS Secretary Robert F. Kennedy Jr. clarified in an interview with Fox News that while some staffing changes were necessary, key programs—including the World Trade Center Health Program and NIOSH—are being merged into a newly established agency named the Administration for a Healthy America. “Those programs were not terminated… But they’ve simply been consolidated into a place that makes more sense,” Kennedy stated.
Restoration of FDA Staff
The reinstatement effort extended to several FDA laboratories as well. Scientists in the agency’s food safety labs located in Chicago and San Francisco received notices confirming the reversal of their layoffs, although some probationary employees remain impacted by the cuts.

Current Status of Other Affected Workers
Despite the announcements, not all employees have received confirmations regarding their reinstatement. Several workers in the FDA’s drug safety labs in Puerto Rico and Detroit have yet to be notified of their job status. Additionally, personnel from the CDC’s National Center for Environmental Health remain off the job, despite earlier assurances about restoring critical expertise in lead poisoning.
Ongoing Layoff Trends
Tuesday’s announcements follow significant layoffs at the National Institutes of Health (NIH), which occurred just days prior. This wave of cuts affected various departments, including the National Cancer Institute and the National Library of Medicine, to meet strict layoff quotas while attempting to maintain vital scientific positions.
As HHS continues to navigate the complexities of restructuring, the future of these pivotal health programs remains a key focus for lawmakers and advocates alike.